A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: Two complementary signals to overcome cross-resistance
- 1 January 2002
- book chapter
- Published by Elsevier
- Vol. 85, 145-174
- https://doi.org/10.1016/s0065-230x(02)85005-9
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The IAP family: endogenous caspase inhibitors with multiple biological activitiesCell Research, 2000
- 5-Fluorouracil Induces Apoptosis through the Suppression of NF-κB Activity in Human Salivary Gland Cancer CellsBiochemical and Biophysical Research Communications, 2000
- Transduction of Apaf-1 or Caspase-9 Induces Apoptosis in A-172 Cells That Are Resistant to p53-Mediated ApoptosisBiochemical and Biophysical Research Communications, 2000
- A Human IAP-Family Gene, Apollon, Expressed in Human Brain Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- STAT-1-Independent Upregulation of FADD and Procaspase-3 and -8 in Cancer Cells Treated with Cytotoxic DrugsBiochemical and Biophysical Research Communications, 1999
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Apoptosis as a goal of cancer therapyCurrent Opinion in Oncology, 1994
- Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxinsCancer Immunology, Immunotherapy, 1992
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987